In 2023, one third of new medicines in the R&D pipeline worldwide were medicines for cancer, while immunology medicines accounted for five percent of new medicines in the R&D pipeline. This graph illustrates the distribution of new medicines in the R&D pipeline worldwide, by therapeutic class.
Distribution of new medicines in the R&D pipeline worldwide as of 2023, by therapeutic class
Includes all pipeline medicines (all stages) that are being developed for market in Canada, the United States, or geographic Europe (excluding Russia and Turkey).
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
PMPRB. (November 12, 2024). Distribution of new medicines in the R&D pipeline worldwide as of 2023, by therapeutic class [Graph]. In Statista. Retrieved December 23, 2024, from https://www.statista.com/statistics/1335988/new-medicines-randd-pipeline-worldwide-share-by-class/
PMPRB. "Distribution of new medicines in the R&D pipeline worldwide as of 2023, by therapeutic class." Chart. November 12, 2024. Statista. Accessed December 23, 2024. https://www.statista.com/statistics/1335988/new-medicines-randd-pipeline-worldwide-share-by-class/
PMPRB. (2024). Distribution of new medicines in the R&D pipeline worldwide as of 2023, by therapeutic class. Statista. Statista Inc.. Accessed: December 23, 2024. https://www.statista.com/statistics/1335988/new-medicines-randd-pipeline-worldwide-share-by-class/
PMPRB. "Distribution of New Medicines in The R&d Pipeline Worldwide as of 2023, by Therapeutic Class." Statista, Statista Inc., 12 Nov 2024, https://www.statista.com/statistics/1335988/new-medicines-randd-pipeline-worldwide-share-by-class/
PMPRB, Distribution of new medicines in the R&D pipeline worldwide as of 2023, by therapeutic class Statista, https://www.statista.com/statistics/1335988/new-medicines-randd-pipeline-worldwide-share-by-class/ (last visited December 23, 2024)
Distribution of new medicines in the R&D pipeline worldwide as of 2023, by therapeutic class [Graph], PMPRB, November 12, 2024. [Online]. Available: https://www.statista.com/statistics/1335988/new-medicines-randd-pipeline-worldwide-share-by-class/